Biotech Values

[wallstarb]

I don't think anyone will want it - NVS decision tainted the drug.

Think of the decision as if your job depended on it - if you licensed it after NVS passed and it eventually failed in phase 2 trials. Everyone would have pointed to the NVS as a red flag that the drug didnt work and you'd be out on the street.